A decrease in serum aldosterone level is associated with maintenance of sinus rhythm after successful cardioversion of atrial fibrillation

PACE - Pacing and Clinical Electrophysiology

Volumn 33, Issue 5, 2010, Pages 561-565

  Wozakowska Kaplon, Beata ^a,b   Bartkowiak, Radoslaw ^a   Janiszewska, Grazyna ^c  

^a Swietokrzyskie Centre of Cardiology   (Poland)

^b Department of Quaternary Studies and Nature Conservation   (Poland)

^c MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Aldosterone; Atrial fibrillation; Cardioversion

Indexed keywords

ALDOSTERONE;

ADULT; ALDOSTERONE BLOOD LEVEL; ARTICLE; CARDIOVERSION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE CONTRACTION; HUMAN; MALE; PROGNOSIS; PROSPECTIVE STUDY; RECURRENT DISEASE; SENSITIVITY AND SPECIFICITY; SINUS RHYTHM; AGED; ARRHYTHMIA, SINUS; ATRIAL FIBRILLATION; BLOOD; HEART LEFT VENTRICLE FUNCTION; MIDDLE AGED; PATHOPHYSIOLOGY; TREATMENT OUTCOME;

AGED; ALDOSTERONE; ARRHYTHMIA, SINUS; ATRIAL FIBRILLATION; ELECTRIC COUNTERSHOCK; FEMALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT;

EID: 77951519327     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2009.02673.x     Document Type: Article

References (12)

1. Vermes E, Tardif JC, Bourassa MG, Racine N, Levesque S, White M, Guerra PG, et al. Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction: Insight from the Studies Of Left Ventricular Dysfunction (SOLVD) trials. Circulation 2003 107 : 2926 2931. (Pubitemid 36736634)
2. Ducharme A, Swedberg K, Pfeffer MA, Cohen-Solal A, Granger CB, Maggioni AP, Michelson EL, et al. Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program. Am Heart J 2006 152 : 86 92. (Pubitemid 43879474)
3. Ehrlich JR, Hohnloser SH, Nattel S. Role of angiotensin system and effects of its inhibition in atrial fibrillation: Clinical and experimental evidence. Eur Heart J 2006 27 : 512 518.
4. Goette A, Staack T, Rocken C, Arndt M, Geller JC, Huth C, Ansorge S, et al. Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation. J Am Coll Cardiol 2000 35 : 1669 1677. (Pubitemid 30307515)
5. Goette A, Hoffmanns P, Enayati W, Meltendorf U, Geller JC, Klein HU. Effect of successful electrical cardioversion on serum aldosterone in patients with persistent atrial fibrillation. Am J Cardiol 2001 88 : 906 909. (Pubitemid 32995932)
6. Schmidt BMW, Schmeider RE. Aldosterone-induced cardiac damage: Focus on blood pressure, independent effects. Am J Hypertens 2003 16 : 80 86. (Pubitemid 36078597)
7. Amir O, Amir RE, Paz H, Mor R, Sagiv M, Lewis BS. Aldosterone synthase gene polymorphism as a determinant of atrial fibrillation in patients with heart failure. Am J Cardiol 2008 102 : 326 329.
8. Berglund H, Boukter S, Theodorsson E, Vallin H, Edhag O. Raised plasma concentrations of atrial natriuretic peptide are independent of left atrial dimensions in patients with chronic atrial fibrillation. Br Heart J 1990 64 : 9 13. (Pubitemid 20222207)
9. Murray KT, Rottman JN, Arbogast PG, Shemanski L, Primm RK, Campbell WB, Solomon AJ, et al. Inhibition of angiotensin II signaling and recurrence of atrial fibrillation in AFFIRM. Heart Rhythm 2004 1 : 669 675. (Pubitemid 40028772)
10. Madrid AH, Bueno MG, Rebollo JM, Marín I, Peña G, Bernal E, Rodriguez A, et al. Use of irbesartan to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation: A prospective and randomized study. Circulation 2002 106 : 331 336. (Pubitemid 34778957)
11. Ueng KC, Tsai TP, Yu WC, Tsai CF, Lin MC, Chan KC, Chen CY, et al. Use of enalapril to facilitate sinus rhythm maintenance after external cardioversion of long-standing persistent atrial fibrillation. Results of a prospective and controlled study. Eur Heart J 2003 24 : 2090 2098.
12. Healey JS, Baranchuk A, Crystal E, Morillo CA, Garfinkle M, Yusuf S, Connolly SJ. Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: A meta-analysis. J Am Coll Cardiol 2005 45 : 1832 1839. (Pubitemid 40789940)